The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 22, 2015
Filed:
Jul. 02, 2013
Applicant:
Sumitomo Chemical Company, Ltd., Tokyo, JP;
Inventors:
Yujiro Hayashi, Tokyo, JP;
Hayato Ishikawa, Tokyo, JP;
Assignee:
Sumitomo Chemical Company, Ltd., Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 231/08 (2006.01); C07C 231/10 (2006.01); C07C 231/12 (2006.01); C07C 233/52 (2006.01); C07C 231/14 (2006.01); C07C 47/198 (2006.01); C07C 205/55 (2006.01); C07C 233/91 (2006.01); C07C 247/22 (2006.01); C07C 323/53 (2006.01); C07C 323/58 (2006.01); C07C 323/59 (2006.01); C07C 323/60 (2006.01); C07C 209/48 (2006.01); C07C 201/12 (2006.01); C07C 227/04 (2006.01); C07C 319/18 (2006.01); C07C 319/20 (2006.01); C07C 239/18 (2006.01); C07C 239/20 (2006.01);
U.S. Cl.
CPC ...
C07C 231/14 (2013.01); C07C 47/198 (2013.01); C07C 201/12 (2013.01); C07C 205/55 (2013.01); C07C 209/48 (2013.01); C07C 227/04 (2013.01); C07C 231/08 (2013.01); C07C 231/10 (2013.01); C07C 231/12 (2013.01); C07C 233/52 (2013.01); C07C 233/91 (2013.01); C07C 239/18 (2013.01); C07C 239/20 (2013.01); C07C 247/22 (2013.01); C07C 319/18 (2013.01); C07C 319/20 (2013.01); C07C 323/53 (2013.01); C07C 323/58 (2013.01); C07C 323/59 (2013.01); C07C 323/60 (2013.01); C07C 2101/14 (2013.01); C07C 2101/16 (2013.01);
Abstract
Disclosed are a process suited to large scale synthesis with high yield for producing oseltamivir phosphate, in which a preparation of oseltamivir phosphate which is highly safe as a pharmaceutical product can be produced, and an intermediate compound for producing oseltamivir phosphate. In this production process, an intermediate compound represented by general formula (V) is synthesized by employing Michael reaction/Michael reaction/Horner-Wadsworth-Emmons reaction, and oseltamivir phosphate is produced by converting the substituent groups in this intermediate compound.